Pricing & Access Strategy Lead (m/f/d) at IGES Gruppe

Nuremberg, Bavaria, Germany -

Full Time

Start Date

Immediate

Expiry Date

31 Aug, 26

Salary

0.0

Posted On

02 Jun, 26

Experience

5 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Market Access Strategy, Pricing Strategy, Reimbursement Analysis, Drug Launch Strategies, Health Technology Assessment, Price Negotiations, Team Leadership, Project Acquisition, Stakeholder Mapping, Healthcare Provision Concepts, Analytical Thinking, Presentation Skills, German Healthcare System Knowledge, SGB V Regulations, EU HTA, Joint Clinical Assessments

Industry

research

Description

About us IGES GmbH specialises in health economic and strategic research and consulting services for international pharmaceutical and medical device manufacturers. It offers biotech, pharmaceutical and medical device companies solutions for market access, pricing and reimbursement of their medical innovations. The company has offices in France, Germany, Italy, Spain, Sweden, Switzerland and the United Kingdom and also provides support for multinational product launches. IGES is part of the Athagoras Group, which brings together various consulting firms for the life sciences industry. To strengthen our team in the Pricing & Access Strategy department, we are looking for a Pricing & Access Strategy Lead (m/f/d) to join us as soon as possible at our offices in Berlin, Basel or Nuremberg Your mission Strategic, technical and personnel management of the Pricing & Access Strategy team, with a focus on drug launch strategies, price negotiations, reimbursement analyses and European market development Providing strategic advice to national and international pharmaceutical companies and biotechs on holistic market access strategies, pricing and reimbursement issues for innovative medicines Development of national and multinational integrated launch strategies and management of the implementation of market access launches Responsibility for product pricing strategies for Germany in close technical and strategic coordination with dossier preparation under Section 35a of the German Social Code, Book V (SGB V) and evidence generation, as well as for projects within the framework of price negotiations under Section 130b of the German Social Code, Book V (SGB V), including preparation, simulation and participation Evaluation of the commercial potential of innovative medicines for Germany and European markets (including the EU HTA context) Continuous monitoring and analysis of health policy developments, as well as the design and evaluation of complex market analyses, stakeholder mappings and healthcare provision concepts Responsibility for project acquisition and the division’s tender strategy, including the evaluation of project enquiries, effort estimates and cost calculations Active involvement in shaping the division’s technical market positioning and service portfolio Representing the division to clients, external experts, scientific bodies and at national and international specialist events Contribution to European corporate strategy and health policy discussions, particularly in the context of EU HTA Your profile A successfully completed degree (Master’s/Diploma) in health sciences, public health, medicine, pharmacy, economics or a comparable qualification Several years’ relevant professional experience in market access, pricing or the early benefit assessment of medicinal products, ideally with experience in consultancy A sound understanding of the structures of the German healthcare system and the relevant regulatory framework Experience in conducting price negotiations in accordance with Section 130b of the German Social Code, Book V Knowledge of national and European HTA procedures is an advantage (including EU HTA and Joint Clinical Assessments) Leadership experience and a strong ability to develop teams Analytical mindset, a high degree of initiative and excellent presentation skills Fluency in spoken and written German and English at an academic level Our offer Opportunity to work on varied projects involving highly innovative medicines at the interface of HTA, pricing and real-world evidence An interdisciplinary, collaborative working environment with flat hierarchies, short decision-making processes and good career prospects Professional and personal development through challenging project work, plenty of scope for your own ideas and tailor-made training programs Flexible working arrangements, including the option to work remotely A permanent position with competitive remuneration, flexible working hours, 30 days’ holiday, plus additional time off on Christmas Eve and New Year’s Eve contact information If this position appeals to you, we look forward to receiving your detailed application (cover letter, CV and references), stating your salary expectations and earliest possible starting date, either via the direct application form or by email to Ms Alina Weber (personal@iges.com). For further information, please contact Ms. Weber on 030/230 809-418.

Responsibilities

Lead the Pricing & Access Strategy team in developing holistic market access and pricing strategies for innovative medicines. Manage drug launch implementations, price negotiations under SGB V, and provide strategic advice to pharmaceutical and biotech companies.